Home | Business News | Browse by Publication | F | FDA Consumer

The FDA approves new leukemia drug; expands use of current drug.

Publication: FDA Consumer
Publication Date: 01-NOV-06
Format: Online
Delivery: Immediate Online Access
Full Article Title: The FDA approves new leukemia drug; expands use of current drug.(Updates)

Article Excerpt
The FDA has granted accelerated approval for Sprycel (dasatinib), a new oral treatment for people with chronic myeloid leukemia (CML), a rare cancer characterized by the uncontrolled growth of white blood cells. CML affects about 4,600 people each year in the United States.

In addition, the FDA approved Sprycel for use in the treatment of adults who have...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from FDA Consumer
New use for Plavix.(Updates), November 01, 2006
Outreach program to teach safe medicine use to middle school children., November 01, 2006
Purchasing pet drugs online: buyer beware., November 01, 2006
First of a kind in HIV treatment., November 01, 2006

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.